A dynamic web-based decision aid to improve informed choice in organised breast cancer screening. A pragmatic randomised trial in Italy
| Autor: | Roberto Cosimo Faggiano, Daniela Luciano, Paola Mosconi, Eugenio Paci, Lina Jaramillo, Livia Giordano, Paola Mantellini, Roberto Satolli, Stefania Caroli, Anna Roberto, Cinzia Colombo, Cinzia Campari, Mario Valenza, Lorenzo Orione, Vanda Marchiò, Bruna Belmessieri, Giulia Candiani, Silvia Deandrea, Liliana Costa, Patrizia Falini, Eva Carnesciali, Anna Silvestri, Roberta Castagno |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Cancer Research
Informed choice medicine.medical_specialty MEDLINE Breast Neoplasms Decisional conflict Article Decision Support Techniques Education 03 medical and health sciences Breast cancer screening 0302 clinical medicine Primary outcome medicine Humans 030212 general & internal medicine Overdiagnosis Early Detection of Cancer Cancer Internet medicine.diagnostic_test business.industry Correction Information quality Middle Aged Italy Socioeconomic Factors Oncology 030220 oncology & carcinogenesis Family medicine Female business Mammography Program Evaluation |
| Zdroj: | British Journal of Cancer |
| ISSN: | 1532-1827 0007-0920 |
| Popis: | Background Improving the quality of information and communication is a priority in organised breast cancer screening and an ethical duty. Programmes must offer the information each woman is looking for, promoting informed decision-making. This study aimed to develop and evaluate a web-based dynamic decision aid (DA). Methods A pragmatic randomised trial carried out in six regional organised screening programmes recruited women at the first invitation receiving DA or a web-based standard brochure (SB). The primary outcome was informed choice measured on knowledge, attitudes, and intentions. Follow-up period: 7–10 days. Secondary outcomes included participation rate, satisfaction, decisional conflict, and acceptability of DA. Results Two thousand one hundred and nineteen women were randomised and 1001 completed the study. Respectively, 43.9% and 36.9% in the DA and SB reached the informed choice. The DA gave a 13-point higher proportion of women aware about overdiagnosis compared to SB (38.3% versus 25.2%, p Conclusion DA increases informed choice. Complete information including the pros, cons, controversies, and overdiagnosis–overtreatment issues boost a woman’s knowledge without reducing the rate of actual screening participation. Clinical trial registration ClinicalTrials.gov number NCT 03097653. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink